Manfred Kraus

Title: Manfred Kraus: Innovator in Cancer Treatment

Introduction

Manfred Kraus is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, Kraus has focused on developing combination therapies that enhance the effectiveness of existing treatments.

Latest Patents

Kraus's latest patents include groundbreaking inventions in the realm of cancer therapies. One of his notable inventions is related to EZH2 inhibitor combination therapies. This invention pertains to combination therapies that comprise an EZH2 inhibitor and a chemotherapeutic agent, along with associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses. Another significant patent involves combinations of a pyrrolidine-2,5-dione IDO1 inhibitor and an antibody. This patent provides combinations of an IDO1 inhibitor, such as a 3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione compound, with an anti-PD1 antibody or anti-PD-L1 antibody, and an anti-4-1BB antibody. These combinations are aimed at treating and preventing cancer and endometriosis.

Career Highlights

Throughout his career, Manfred Kraus has worked with prominent companies in the pharmaceutical industry. He has been associated with Pfizer Corporation and Iteos Therapeutics, where he has contributed to the development of innovative therapies. His work has been instrumental in advancing cancer treatment options.

Collaborations

Kraus has collaborated with esteemed colleagues in his field, including Pei-Pei Kung and Thomas Andrew Paul. These collaborations have further enriched his research and development efforts.

Conclusion

Manfred Kraus stands out as an influential inventor in the field of cancer treatment. His innovative patents and collaborations have the potential to significantly impact the future of cancer therapies. His contributions continue to pave the way for advancements in medical science.